Results 31 to 40 of about 213 (114)
Effect of hypoglycemic therapy on fat metabolism
Медицинский совет, 2014 Diabetes mellitus (DM type 2) is a chronic, progressive heterogeneous disease. According to the WHO, the number of patients with DM type 2 is nearly 370 million people. In 80-90% of cases [1] DM type 2 is associated with obesity. Abdominal (visceral) fat
M. S. Abayeva
doaj +1 more source
, 2022 Метформин је широко употребљивани антидијабетик. Показано је да системски примењен метформин испољава антиноцицептивни ефекат у који су укључени одређени серотонински рецептори.Metformin is a widely used antidiabetic.
Gajić, Veljko, Grahovac, Anđela
core
The effects of obesity and insulin resistance on women's reproductive health
Медицинский совет, 2015 Obesity, a new "non-infectious" global epidemic, overwhelmed most of developed countries all over the world and is regarded as one of the reasons for a steady decline in the reproductive potential of people today.
S. Y. Kalinchenko +3 more
doaj +1 more source
The efficacy of systemic treatment of androgen-dependent dermopathy in women of reproductive age
Медицинский совет, 2015 Due to the associated serious endocrine and metabolic disorders, hyperandrogenic conditions result in skin lesions and deterioration of the quality of life.
I. V. Kuznetsova +3 more
doaj +1 more source
Mechanisms of metformin action [PDF]
, 2021 The article discusses modern hypotheses regarding the mechanisms of metformin action. Metformin has been shown to affect not only carbohydrate metabolism, but also many other cell functionsВ статье рассматриваются современные гипотезы о механизмах ...
Izmozherova, N. V. +5 more
core
Nonalcoholic fatty liver disease in patients with type 2 diabetes
Медицинский совет, 2016 The problem of NAFLD has been a matter of great interest among gastroenterologists, as well as endocrinologists and cardiologists. NAFLD is currently considered a component of hepatic metabolic syndrome.
N. A. Petunina, M. E. Tel'nova
doaj +1 more source
Сахарный диабет, 2006 Цель. Сравнить качество контроля гликемии посредством монотерапии БИАсп 30 или в комбинации с метформином по сравнению с терапией сульфонилмочевинным препаратом глибенкламидом в комбинации с метформином у больных СД 2 типа, у которых не удается добиться ...
M Kvapil +3 more
doaj +1 more source
, 2018 Diabetes mellitus (DM) is a national health priority in the world and in Ukraine too.Aim. To substantiate the choice of regimens for combined therapy of type 2 DM (T2DM).Materials and methods.
Germanyuk, T. A. +2 more
core +1 more source
Сахарный диабет, 2008 Цель. Оценка влияния терапии метформином на углеводный и липидный обмен, оценив изменение параметров кинетики глюкозы в ходе ВТТГ и динамику уровня лептина у больных СД2, ранее не получавших медикаментозную сахароснижающую терапию.
Alexander Vasil'evich Dreval' +3 more
doaj +1 more source
, 2017 Метформин може да повлияе туморогенезата чрез АМРК по два механизма - индиректно: систематично намаляване на инсулиновите нива и директно: чрез индукция на енергетичен стрес.
Teneva, Tatyana; Multi-profile Hospital for Active Treatment - Elin Pelin +1 more
core +1 more source